I would be very surprised if they could now test product which has been used. Why would they go to the trouble of keeping left over stems? What, refreezing after use where at the time there was no need to? Pay for the cost of keeping all product used in SI’s freezer? Highly unlikely.
Again, why would they “extensively test” beforehand, when they had no idea there was the quality control problems which only materialised late in the show when the FDA raised it? What would they test for? What, just everything? Answer is they wouldn’t have.
I was not aware that msb are testing all stock on hand. Is that just a bit of the Koolaid talking or is there some evidence of this?
I’m betting it’s the Koolaid.
MSB 2022 - The road to commercialisation, page-1186
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.39 |
Change
-0.075(5.12%) |
Mkt cap ! $1.587B | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.46 | $1.37 | $9.337M | 6.672M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 80200 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 28642 | 2 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |